Siemens and Medtronic introduce a joint range of products at the EACTS
During the Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS) from October 17 to 21, 2009, Siemens Healthcare and Medtronic will jointly present their range of hybrid operating rooms (ORs) in which both interventional and surgical operations can be performed. Furthermore, on October 19 Medtronic and Siemens will be holding a lunch symposiumon the topic of 'Lifetime management of patients with aortic valve diseases'.
Another highlight will be the live transmission of a transapical aortic valve implantation fromthe hybrid OR of the Leipzig Heart Center to be performed by Prof. Dr. Walther, the Senior Physician in Charge. This operation can be viewed during the Techno- College to be held on October 17.
During the 23rd Annual Meeting of the European Association for Cardio-Thoracic Surgery in Vienna, Siemens and Medtronic will present innovative solutions for hybrid ORs within the scope of their partnership agreement. These include, for example, the transcatheter valves from Medtronic.
The latter are artificial heart valves which can be implanted in the heart via a catheter. This operation requires fluoroscopy systems which supply an image quality with details that are not available from the mobile C-arm X-ray systems used in conventional ORs. This is where the Artis zeego angiography system from Siemens comes into play. The system enables the physician to position the C-arm virtually anywhere in the area surrounding the patient and produce new types of clinical images, e.g. a 3D representation with a live fluoro overlay.
The physician can thus check whether the new valve is optimally positioned and functioning properly at any time. In addition, with Performer CPB, Medtronic offers a compact heart-lung machine which can be used flexibly and efficiently in the hybrid OR. Furthermore, using the Bio-Medicus cannulae from Medtronic, extracorporeal circulatory support can be set up very quickly in the hybrid OR.
Rob ten Hoedt, President of Medtronic in Europe and Central Asia explained: "New developments in the fields of heart surgery and interventional cardiology enable less invasive therapy for many heart and vascular conditions. The alliance between Medtronic and Siemens enables us to offer physicians an optimized hybrid operating room solution which is the ideal environment to perform these less invasive procedures. This catheter based approach brings new treatment option for patients who are not indicated for conventional surgery, thereby fulfilling Medtronic’s Mission of alleviating pain, restoring health and extending life."
Heinrich Kolem, CEO of Angio, Fluoroscopic and Radiographic Systems at Siemens Healthcare, adds: “Siemens offers its customers integrated hybrid OR solutions in the field of surgery. Such solutions can be made possible only through partnerships with companies that share the same vision for the future of heart surgery. And that's the reason why we work together with companies like Medtronic, who offer outstanding devices and perfusion solutions for the hybrid OR."
In addition to their hybrid OR range, Siemens and Medtronic also collaborate on advanced training for physicians. Thus, for example, the two companies have developed training programs dealing with imaging and handling catheters in cardiovascular surgery. Following a theoretical part, the course participants train on simulators and on angiography systems which use real radiation. In the practical part, an experienced surgeon is available for every two participants. Intensive training in small groups ensures learning success.
Heart and vascular surgery is one of the most commonly used and, at the same time, one of the most complex procedures in modern medicine. Some 260,000 patients are currently afflicted with severe aortic stenosis inWestern Europe alone. Of these, roughly 50,000 are regarded as inoperable due to their risk profiles. New developments in surgical procedures such as, for example, the replacement of heart valves via catheter and the implantation of stents in the thoracic aorta now promise better therapeutic possibilities for such patients. The ideal environment for such treatments is the so-called hybrid operating room, which represents a synthesis between a cardiosurgical operating room and a cardiac cath lab. In addition to conventional OR equipment including a heart-lung machine and a complete angiography system, it also features a C-arm which is capable of revolving around the patient, thus providing images similar to the scans generated by a CT scanner. These new hybrid operating rooms enable surgeons and cardiologists to efficiently perform new and promising treatment procedures, especially in the fields of heart and vascular surgery, e.g. heart valve implantations and the insertion of stents in the thoracic aorta.
Medtronic, Inc., headquartered in Minneapolis, is the world’s leading medical technology company, alleviating pain, restoring health and extending life for people with chronic disease.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros.
Visualizing gene expression with MRI
23.12.2016 | California Institute of Technology
Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery
21.12.2016 | UT Southwestern Medical Center
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.
The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
17.01.2017 | Earth Sciences
17.01.2017 | Materials Sciences
17.01.2017 | Architecture and Construction